Per Kongsted

Long-Lasting Complete Responses in Patients with Metastatic Melanoma after Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes and an Attenuated IL2 Regimen

Rikke Andersen, Marco Donia, Troels Holz Borch et al. · Clinical Cancer Research · 2016 · 306 citations · Full text

Life Sciences, Immunology, Oncology +17

Correlation between frequencies of blood monocytic myeloid-derived suppressor cells, regulatory T cells and negative prognostic markers in patients with castration-resistant metastatic prostate cancer

Manja Idorn, Tania Køllgaard, Per Kongsted et al. · Cancer Immunology Immunotherapy · 2014 · 184 citations · Full text

Medicine, Immunology, Oncology +17

Dendritic cell vaccination in combination with docetaxel for patients with metastatic castration-resistant prostate cancer: A randomized phase II study

Per Kongsted, Troels Holz Borch, Trine Zeeberg Iversen et al. · Cytotherapy · 2017 · 89 citations

Medicine, Immunology, Oncology +16

T cells isolated from patients with checkpoint inhibitor-resistant melanoma are functional and can mediate tumor regression

Rikke Andersen, Troels Holz Borch, Arianna Draghi et al. · Annals of Oncology · 2018 · 76 citations · Full text

Life Sciences, Immunology, Oncology +17

Tryptophan 2,3-dioxygenase (TDO)-reactive T cells differ in their functional characteristics in health and cancer

Mads Duus Hjortsø, Stine Kiær Larsen, Per Kongsted et al. · OncoImmunology · 2014 · 31 citations · Full text

Life Sciences, Immunology, Oncology +16